LMNA and lipodystrophy: Like HGPS patients, these mice express progerin ubiquitously and age prematurely, and they display the main clinical manifestations of the human disease, including lipodystrophy, bone and cardiovascular abnormalities, and reduced lifespan (Hamczyk, Villa‐Bellosta et al., 2018; Osorio et al., 2011; Villa‐Bellosta et al., 2013).